<DOC>
	<DOCNO>NCT00759629</DOCNO>
	<brief_summary>The objective international , multicenter , randomize study ass whether coronary artery stenting associate reduce infarct size patient AMI present 12 48 hour onset symptom compare medical treatment alone</brief_summary>
	<brief_title>Beyond 12 Hours Reperfusion AlternatiVe Evaluation Trial</brief_title>
	<detailed_description>Between 8.5 % 40 % patient acute myocardial infarction present late symptom onset , longer eligible thrombolysis.Despite effort reduce time presentation , recent study demonstrate time-to-arrival changed.The lack efficacy thrombolysis patient acute MI present &gt; 12 hour symptom onset may reason current guideline oppose reperfusion therapy setting.Several finding suggest , however , reperfusion therapy may beneficial even among patient . First , recent study show viable salvageable myocardium exist even &gt; 12 hour severe ischemia . Second , previous study demonstrate PCI good thrombolysis patient acute MI , also time window efficacy PCI may wider thrombolysis.Third , observational study suggest PCI effective even perform 12 hour symptom onset patient acute MI . The goal trial ass whether invasive strategy base PCI stenting associate reduction infarct size patient acute STEMI present &gt; 12 hour symptom onset compare conventional conservative treatment strategy .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>patient fulfil criterion AMI present hospital 12 48 hour onset symptom . The criterion AMI fulfil least one episode typical chest pain last ≥ 20 minute combine either unequivocal ECG change ( ≥ 0.1 mV STsegment elevation ≥ 2 limb lead ≥ 0.2 mV ≥ 2 contiguous precordial lead new pathological Qwaves ) CK plus concomitant CKMB increase twice upper normal threshold . All patient inform nature study give inform consent participation study . Age &lt; 18 year &gt; 80 year Cardiogenic shock ( systolic blood pressure &lt; 80 mm Hg unresponsive fluid necessitate infusion catecholamine : GUSTO I criteria ) Persistent severe chest pain Prior thrombolysis ( index AMI ) Malignancies life expectancy &lt; 1year History bleed diathesis , coagulopathy Contraindications antithrombotic therapy use conjunction coronary stenting ( clopidogrel abciximab ) Stroke within past 3 month Major surgery within past 30 day Platelets &lt; 100000/mm3 &gt; 700000/mm3 , Hb &lt; 10g/dl , white blood cell count &lt; 3000/mm3 Percutaneous coronary intervention within past 30 day Inability cooperate study procedure and/or followup Previous enrollment trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>